Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential gene expression in human cerebrovascular malformations.

Robert Shenkar1, J Paul Elliott, Katrina Diener

  • 1Center for Cellular and Molecular Neurosurgery, Department of Neurosurgery, University of Colorado Health Sciences Center, Denver, Colorado, USA.

Neurosurgery
|January 22, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TIE2 links MEKK3-KLF2/4 and PI3K signaling in cerebral cavernous malformation.

The Journal of experimental medicine·2026
Same author

The future of fundamental science led by generative closed-loop artificial intelligence.

Frontiers in artificial intelligence·2026
Same author

Microvascular decompression of aberrantly looped anterior inferior cerebellar artery: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or Placebo.

Journal of the American Heart Association·2026
Same author

Improving biomedical entity linking with generative relevance feedback.

Bioinformatics (Oxford, England)·2026
Same author

Integration of artificial intelligence and high-content screening enabled identification of drugs for long-term treatment of cerebral cavernous malformation disease.

bioRxiv : the preprint server for biology·2025

Researchers identified numerous differentially expressed genes in cerebral cavernous malformations (CCMs) and arteriovenous malformations (AVMs). This study advances understanding of cerebrovascular malformations by correlating gene expression with immunohistochemistry.

Area of Science:

  • Vascular biology
  • Genomics
  • Molecular pathology

Background:

  • Cerebral cavernous malformations (CCMs) and arteriovenous malformations (AVMs) are complex cerebrovascular lesions.
  • Understanding the molecular underpinnings of CCMs and AVMs is crucial for developing targeted therapies.

Purpose of the Study:

  • To identify genes with differential expression in CCMs and AVMs compared to control superficial temporal arteries (STAs).
  • To confirm differential expression of previously implicated genes in the pathobiology of these vascular malformations.

Main Methods:

  • Messenger RNA (mRNA) expression levels were quantified using human gene arrays from surgical specimens of CCMs, AVMs, and STAs.
  • Two distinct analytical methodologies, gene discovery and confirmation analysis, were employed to analyze the expression data.

Related Experiment Videos

Main Results:

  • Gene discovery identified 42 up-regulated and 36 down-regulated genes in CCMs versus AVMs/STAs (P = 0.006).
  • Gene discovery identified 48 up-regulated and 59 down-regulated genes in AVMs versus CCMs/STAs (P = 0.006).
  • Confirmation analysis revealed significant differential expression in 11 of 15 previously implicated genes (P < 0.05).

Conclusions:

  • Numerous differentially expressed genes were identified in CCMs and AVMs.
  • Gene expression patterns correlate with immunohistochemistry findings for genes involved in cerebrovascular malformations.
  • Future research will focus on confirming candidate genes and elucidating their biological and mechanistic relevance in cerebrovascular malformations.